Mr. Speaker, as I have said before in the House, we are dealing with a global shortage of TC99. We have been working with the medical community in Canada to look at alternatives to TC99 to mitigate the impact of the global shortage of supply.

    We continue to work with the international community and encourage the medical community to apply for a special access program so that the supply of TC99 can be made available in Canada.